You are here

TMC435

Idenix Pharma Initiates Phase II Study

Yahoo/Zacks

Sat, 06/1/13 - 12:06 pm

Invest in the Great Progress of Hepatitis C

Motley Fool

Sat, 12/8/12 - 11:17 am

Gilead Sciences

5 Biotech Stocks That Could Soar On New Hepatitis C Drugs

Seeking Alpha

Sat, 04/21/12 - 12:17 pm

Abbott Laboratories

Medivir Announces TMC435 in an Expanded Clinical Collaboration

Yahoo

Wed, 04/18/12 - 09:14 am

Bristol-Myers Squibb

Drugmakers target hepatitis C

Yahoo/Investor's Business Daily

Sat, 12/3/11 - 03:57 pm

Bristol-Myers Squibb

declatasvir. Ribavirin

Bristol-Myers and J&J will study a combination of 2 of their hepatitis C drug candidates

Yahoo/AP

Fri, 12/2/11 - 12:04 pm

Bristol-Myers Squibb

J&J Has to Resolve Hepatitis C Drug Conflict, Medivir CEO Says

Bloomberg

Wed, 07/13/11 - 08:23 am

Vertex Pharmaceuticals